GlassScriptPhysician profile
Tiffany A Malone
NPI 1205831153
$4,999.94
in general payments reported to CMS, 2019-2025
11 companies · $1,776 in 2025
The $1,776 reported for 2025 was more than what 96% of Optometrist providers received nationally (typical 2025 total: $204).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $283 · 2020: $259 · 2021: $606 · 2022: $806 · 2023: $703 · 2024: $567 · 2025: $1,776.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,523 · Consulting Fee: $1,523.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,523.31 |
| Consulting Fee | $1,522.67 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Johnson & Johnson Vision Care, INC. | $3,902.88 | 2020-2025 | Acuvue |
| Alcon Vision LLC | $312.18 | 2019-2022 | |
| Bausch & Lomb, A Division of Bausch Health US, LLC | $279.10 | 2019-2021 | |
| Kala Pharmaceuticals, INC. | $213.23 | 2021 | |
| Bausch & Lomb Americas INC. | $97.13 | 2024 | Miebo, Xiidra |
| Sun Pharmaceutical Industries INC. | $97.03 | 2023 | Cequa |
| Maculogix, INC. | $31.18 | 2019 | |
| Abbvie INC. | $24.05 | 2022 | |
| Sight Sciences, INC. | $21.52 | 2022 | |
| Biotissue Holdings INC. | $16.16 | 2024 | |
| Abb Con-Cise Optical Group LLC | $5.48 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Tiffany Malone listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.